North America Artificial Intelligence (Ai) In Healthcare Market 2024-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	115 Pages	Triton Market Research	March, 2024	TRTN18642493

Best Price Guarantee
Price	from $1,500
Length	115 Pages
Publisher	Triton Market Research
Published Date	March, 2024
SKU	TRTN18642493

North America Artificial Intelligence (Ai) In Healthcare Market 2024-2032

Market Outlook

Triton’s research states that the North America artificial intelligence (AI) in healthcare market is projected to progress with a CAGR of 36.48% during the projected years 2024-2032. Canada and the United States are evaluated in this region.

Significant investments in R&D to improve and implement artificial intelligence are driving the growth of the market in Canada. As per a Canadian government report, the establishment of the Vector Institute in Ontario is specifically aimed at advancing AI in healthcare. With a combined investment from government and private entities, the Vector Institute is playing a crucial role in fostering AI’s expansion in healthcare. In 2024, Merck Canada announced a partnership with the Vector Institute to further enhance its AI capabilities and spur innovation in healthcare. Hence, these developments fuel the AI in healthcare market’s growth to a large extent.

In late October 2023, the US Food and Drug Administration (FDA) unveiled its inaugural action plan focused on AI and machine learning, aiming to enhance its oversight of sophisticated medical software. This initiative coincided with a broad executive order from the Biden Administration, tasking various federal agencies with assessing the potential ramifications of Artificial 0Intelligence (AI) and crafting strategies to foster innovation while addressing any adverse effects, particularly within the healthcare domain.

Competitive Outlook

The major companies in the AI in healthcare market include Google LLC, Medtronic Plc, Microsoft Corporation, Oncora Medical, Stryker Corporation, and Intel Corporation.

1. North America Artificial Intelligence (Ai) In Healthcare Market - Summary
2. Industry Outlook: 2.1. Porter’s Five Forces Analysis; 2.1.1. Buyers Power; 2.1.2. Suppliers Power; 2.1.3. Substitution; 2.1.4. New Entrants; 2.1.5. Industry Rivalry; 2.2. Market Maturity Analysis; 2.3. Value Chain Analysis; 2.3.1. Data Warehouse; 2.3.2. Artificial Intelligence (Ai) Analysis; 2.3.3. Software Development; 2.4. Key Buying Criteria; 2.4.1. Application; 2.4.2. Technology; 2.4.3. Integration With Existing Infrastructure; 2.5. Regulatory Framework; 2.6. Key Market Strategies; 2.6.1. Acquisitions; 2.6.2. Product Launches; 2.6.3. Collaborations; 2.7. Market Drivers; 2.7.1. Adoption Of Ai Being Supported By Large Volumes Of Healthcare Data; 2.7.2. Personalized Medicine In Tests For Clinical Decision-making; 2.7.3. Growing Proactive Government Support And Investments In Ai R&D; 2.7.4. Increasing Start-ups In Ai And Machine Learning; 2.8. Market Challenges; 2.8.1. Cost Constraints And A Low Return On Investment (Roi); 2.8.2. Challenges In Sustaining Data Security; 2.8.3. Slow Adoption Of Ai-based Technologies; 2.9. Market Opportunities; 2.9.1. Expanding Applications Of Ai In The Healthcare Industry; 2.9.2. Rising Demand For Ai In Drug Discovery; 2.9.3. Strong Focus On The Development Of Precision Medicine And Personalized Drugs; 2.9.4. Ai Used To Establish A Real-time Monitoring System; 2.10. Analyst Perspective
3. North America Artificial Intelligence (Ai) In Healthcare Market - By Solution: 3.1. Software; 3.2. Services; 3.3. Hardware
4. North America Artificial Intelligence (Ai) In Healthcare Market - By Technology: 4.1. Natural Language Processing; 4.2. Querying Method; 4.3. Context Aware Processing; 4.4. Deep Learning
5. North America Artificial Intelligence (Ai) In Healthcare Market - By Type: 5.1. Robot-assisted Surgery; 5.2. Virtual Nursing Assistant; 5.3. Administrative Workflow Assistance; 5.4. Fraud Detection; 5.5. Dosage Error Reduction; 5.6. Clinical Trial Participant Identifier; 5.7. Preliminary Diagnosis; 5.8. Other Applications
6. North America Artificial Intelligence (Ai) In Healthcare Market - By Industry Vertical: 6.1. Healthcare Providers; 6.2. Pharmaceutical And Biotechnology Companies; 6.3. Payers; 6.4. Acos And Mcos; 6.5. Patients
7. North America Artificial Intelligence (Ai) In Healthcare Market – By Country Outlook: 7.1. United States; 7.1.1. United States Artificial Intelligence (Ai) In Healthcare Market Forecast & Prospects; 7.2. Canada; 7.2.1. Canada Artificial Intelligence (Ai) In Healthcare Market Forecast & Prospects
8. Competitive Landscape: 8.1. Ge Healthcare; 8.1.1. Overview; 8.1.2. Product List; 8.1.3. Key Strengths; 8.1.4. Key Challenges; 8.2. General Vision Inc; 8.2.1. Overview; 8.2.2. Product List; 8.3. Google Llc; 8.3.1. Overview; 8.3.2. Product List; 8.3.3. Key Strengths; 8.3.4. Key Challenges; 8.4. Ibm Corporation; 8.4.1. Overview; 8.4.2. Product List; 8.4.3. Key Strengths; 8.4.4. Key Challenges; 8.5. Intel Corporation; 8.5.1. Overview; 8.5.2. Product List; 8.5.3. Key Strengths; 8.5.4. Key Challenges; 8.6. Koninklijke Philips Nv; 8.6.1. Company Overview; 8.6.2. Products; 8.6.3. Key Strengths; 8.6.4. Key Challenges; 8.7. Medtronic Plc; 8.7.1. Company Overview; 8.7.2. Product List; 8.7.3. Key Strengths; 8.7.4. Key Challenges; 8.8. Microsoft Corporation; 8.8.1. Company Overview; 8.8.2. Product List; 8.8.3. Key Strengths; 8.8.4. Key Challenges; 8.9. Nvidia Corporation; 8.9.1. Overview; 8.9.2. Product List; 8.9.3. Key Strengths; 8.9.4. Key Challenges; 8.10. Oncora Medical; 8.10.1. Overview; 8.10.2. Product List; 8.11. Recursion Pharmaceuticals Inc; 8.11.1. Overview; 8.11.2. Products; 8.12. Stryker Corporation; 8.12.1. Overview; 8.12.2. Product List; 8.12.3. Key Strengths; 8.12.4. Key Challenges; 8.13. Siemens Healthineers Ag; 8.13.1. Overview; 8.13.2. Product List; 8.13.3. Key Strengths; 8.13.4. Key Challenges
9. Research Methodology & Scope: 9.1. Research Scope & Deliverables; 9.1.1. Objectives Of Study; 9.1.2. Scope Of Study; 9.2. Sources Of Data; 9.2.1. Primary Data Sources; 9.2.2. Secondary Data Sources; 9.3. Research Methodology; 9.3.1. Evaluation Of Proposed Market; 9.3.2. Identification Of Data Sources; 9.3.3. Assessment Of Market Determinants; 9.3.4. Data Collection; 9.3.5. Data Validation & Analysis
List Of Tables: Table 1: North America Artificial Intelligence (Ai) In Healthcare Market, By Country Outlook, Historical Years, 2020-2023 (In $ Million); Table 2: North America Artificial Intelligence (Ai) In Healthcare Market, By Country Outlook, Forecast Years, 2024-2032 (In $ Million); Table 3: List Of Acquisitions; Table 4: List Of Product Launches; Table 5: List Of Collaborations; Table 6: North America Artificial Intelligence (Ai) In Healthcare Market, By Solution, 2024-2032 (In $ Million); Table 7: North America Artificial Intelligence (Ai) In Healthcare Market, By Technology, 2024-2032 (In $ Million); Table 8: North America Artificial Intelligence (Ai) In Healthcare Market, By Type, 2024-2032 (In $ Million); Table 9: North America Artificial Intelligence (Ai) In Healthcare Market, By Industry Vertical, 2024-2032 (In $ Million); Table 10: North America Artificial Intelligence (Ai) In Healthcare Market, By Country Outlook, 2024-2032 (In $ Million)
List Of Figures: Figure 1: Porter’s Five Forces Analysis; Figure 2: Market Maturity Analysis; Figure 3: Value Chain Analysis; Figure 4: North America Artificial Intelligence (Ai) In Healthcare Market, By Solution, 2023 & 2032 (In %); Figure 5: North America Artificial Intelligence (Ai) In Healthcare Market, By Software, 2024-2032 (In $ Million); Figure 6: North America Artificial Intelligence (Ai) In Healthcare Market, By Services, 2024-2032 (In $ Million); Figure 7: North America Artificial Intelligence (Ai) In Healthcare Market, By Hardware, 2024-2032 (In $ Million); Figure 8: North America Artificial Intelligence (Ai) In Healthcare Market, By Technology, 2023 & 2032 (In %); Figure 9: North America Artificial Intelligence (Ai) In Healthcare Market, By Natural Language Processing, 2024-2032 (In $ Million); Figure 10: North America Artificial Intelligence (Ai) In Healthcare Market, By Querying Method, 2024-2032 (In $ Million); Figure 11: North America Artificial Intelligence (Ai) In Healthcare Market, By Context Aware Processing, 2024-2032 (In $ Million); Figure 12: North America Artificial Intelligence (Ai) In Healthcare Market, By Deep Learning, 2024-2032 (In $ Million); Figure 13: North America Artificial Intelligence (Ai) In Healthcare Market, By Type, 2023 & 2032 (In %); Figure 14: North America Artificial Intelligence (Ai) In Healthcare Market, By Robot-assisted Surgery, 2024-2032 (In $ Million); Figure 15: North America Artificial Intelligence (Ai) In Healthcare Market, By Virtual Nursing Assistant, 2024-2032 (In $ Million); Figure 16: North America Artificial Intelligence (Ai) In Healthcare Market, By Administrative Workflow Assistance, 2024-2032 (In $ Million); Figure 17: North America Artificial Intelligence (Ai) In Healthcare Market, By Fraud Detection, 2024-2032 (In $ Million); Figure 18: North America Artificial Intelligence (Ai) In Healthcare Market, By Dosage Error Reduction, 2024-2032 (In $ Million); Figure 19: North America Artificial Intelligence (Ai) In Healthcare Market, By Clinical Trial Participant Identifier, 2024-2032 (In $ Million); Figure 20: North America Artificial Intelligence (Ai) In Healthcare Market, By Preliminary Diagnosis, 2024-2032 (In $ Million); Figure 21: North America Artificial Intelligence (Ai) In Healthcare Market, By Other Types, 2024-2032 (In $ Million); Figure 22: North America Artificial Intelligence (Ai) In Healthcare Market, By Industry Vertical, 2023 & 2032 (In %); Figure 23: North America Artificial Intelligence (Ai) In Healthcare Market, By Healthcare Providers, 2024-2032 (In $ Million); Figure 24: North America Artificial Intelligence (Ai) In Healthcare Market, By Pharmaceutical And Biotechnology Companies, 2024-2032 (In $ Million); Figure 25: North America Artificial Intelligence (Ai) In Healthcare Market, By Payers, 2024-2032 (In $ Million); Figure 26: North America Artificial Intelligence (Ai) In Healthcare Market, By Acos And Mcos, 2024-2032 (In $ Million); Figure 27: North America Artificial Intelligence (Ai) In Healthcare Market, By Patients, 2024-2032 (In $ Million); Figure 28: North America Artificial Intelligence (Ai) In Healthcare Market, By Country Outlook, 2023 & 2032 (In %); Figure 29: United States Artificial Intelligence (Ai) In Healthcare Market 2024-2032 (In $ Million); Figure 30: Canada Artificial Intelligence (Ai) In Healthcare Market 2024-2032 (In $ Million)